T. Rohde

发表

Implantable Pumps and Ports

H. Buchwald, T. Rohde, 2001 .

A Totally Implantable Drug Infusion Defice: Laboratory and Clinical Experience Using a Model with Single Flow Rate and New Design for Modulated Insulin Infusion

P. Blackshear, R. Varco, H. Buchwald, 1980, Diabetes Care.

The use of an implantable insulin pump in the treatment of type II diabetes.

H Buchwald, F D Dorman, T D Rohde, 1982, The New England journal of medicine.

TREATMENT OF A TYPE II DIABETIC BY A TOTALLY IMPLANTABLE INSULIN INFUSION DEVICE

P. Blackshear, R. Varco, H. Buchwald, 1981, The Lancet.

One year of continuous heparinization in the dog using a totally implantable infusion pump.

P. Blackshear, R. Varco, H. Buchwald, 1975, Surgery, gynecology & obstetrics.

PROTRACTED PARENTERAL DRUG INFUSION IN AMBULATORY SUBJECTS USING AN IMPLANTABLE INFUSION PUMP

P. Blackshear, R. Varco, H. Buchwald, 1977, Transactions - American Society for Artificial Internal Organs.

One year of heparin anticoagulation. An ambulatory subject using a totally implantable infusion pump.

P. Blackshear, R. Varco, H. Buchwald, 1977, Minnesota medicine.

Design and initial testing of a totally implantable transcutaneously controllable insulin delivery device.

P. Blackshear, R. Varco, H. Buchwald, 1978, Transactions - American Society for Artificial Internal Organs.

Control of Blood Glucose in Experimental Diabetes by Means of a Totally Implantable Insulin Infusion Device

P. Blackshear, R. Varco, H. Buchwald, 1979, Diabetes.

Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump

P. Blackshear, R. Varco, H. Buchwald, 1980, Cancer.

Glycerol Prevents Insulin Precipitation and Interruption of Flow in an Implantable Insulin Infusion Pump

P. Blackshear, H. Buchwald, T. Rohde, 1983, Diabetes Care.

Implantable Continuous Intravenous Insulin Infusion Device: Restoration of Flow after Slow‐Down

H. Buchwald, T. Rohde, F. Dorman, 1986, ASAIO transactions.

An improved glycerol/insulin formulation for use in implantable pumps.

H. Buchwald, K. Kernstine, T. Rohde, 1987, ASAIO transactions.

The spring-driven implantable pump. A low-cost alternative.

H. Buchwald, T. Rohde, F. Dorman, 1992, ASAIO journal.

Insulin delivery by implanted pump. A chronic treatment for diabetes.

H Buchwald, T D Rohde, H. Buchwald, 1989, ASAIO transactions.

An implantable pump for long-term intravascular drug infusion.

P. Blackshear, H. Buchwald, T. Rohde, 1981, Medical instrumentation.

Decreased blood oxygen diffusion in hypercholesterolemia.

H. Buchwald, T. Rohde, H. Menchaca, 1998, Surgery.

Implantable pumps. Recent progress and anticipated future advances.

H. Buchwald, T. Rohde, 1992, ASAIO journal.

Effect Of Plasma Cholesterol On Red Blood Cell Oxygen Transport

H. Buchwald, T. Rohde, H. Menchaca, 2000, Clinical and experimental pharmacology & physiology.

Implantable insulin pump in type II diabetes.

H. Buchwald, M. Bergman, T. Rohde, 1982, The New England journal of medicine.

Failure to find amyloidosis in dogs treated with long-term intravenous insulin delivered by a totally implantable pump

M. Steffes, H. Buchwald, S. Mauer, 1983, Diabetologia.

Implantable Infusion Pump Management of Insulin Resistant Diabetes Mellitus

B. Hoogwerf, H. Buchwald, T. Rohde, 1985, Annals of surgery.

Use of polyethylene-lined silicone rubber cannulae in long-term insulin infusion in the dog.

H. Buchwald, T. Rohde, F. Dorman, 1986, ASAIO transactions.

Reduction of plasma cholesterol and LDL-cholesterol by continuous intravenous insulin infusion.

H. Buchwald, T. Rohde, W. Rupp, 1985, Surgery.

Diabetic nephropathy in the uninephrectomized dog: microscopic lesions after one year.

P. Blackshear, M. Steffes, H. Buchwald, 1982, Kidney international.

The effect of continuous heparin infusion for one year on serum cholesterol and triglyceride concentrations in the dog.

P. Blackshear, R. Varco, H. Buchwald, 1977, Atherosclerosis.

The implantable infusion pump: a new concept in drug delivery.

P. Blackshear, H. Buchwald, T. Rohde, 1979, Medical progress through technology.

Improvement of Blood Oxygen Diffusion Capacity and Anginal Symptoms by Cholesterol Lowering with Simvastatin

Henry Buchwald, H. Buchwald, A. Hirsch, 2004 .

Plasma cholesterol: an influencing factor in red blood cell oxygen release and cellular oxygen availability.

H Buchwald, T J O'Dea, T D Rohde, 2000, Journal of the American College of Surgeons.

Long-term heparin administration in ambulatory subjects using an implantable infusion pump

P. Blackshear, H. Buchwald, T. Rohde, 1978 .

Pilot study of oxygen transport rate of banked red blood cells

H. Buchwald, T. Rohde, J. Connett, 2009, Vox sanguinis.

Risk of osteoporosis in patients treated with long-term intravenous heparin therapy.

P. Blackshear, H. Buchwald, T. Rohde, 1982, Current surgery.

Long-term, continuous intravenous heparin administration by an implantable infusion pump in ambulatory patients with recurrent venous thrombosis.

H Buchwald, P D Schneider, T D Rohde, 1980, Surgery.

Implantable infusion pumps.

H. Buchwald, T. Rohde, 1984, Advances in surgery.

A novel device for measuring the effect of cholesterol on the release of oxygen from red blood cells

H. Buchwald, T. Rohde, H. Menchaca, 2000, Proceedings of the 22nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (Cat. No.00CH37143).